Labcorp Holdings Inc.

Labcorp Holdings Inc.

LHยทNYSE

$258.92

+0.47%
HealthcareMedical - Diagnostics & Research

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

At a Glance

Live Snapshot
Market Cap$21.23B
EPS10.5400
P/E Ratio24.57
Earnings Date07/23/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

High confidence

Valuation multiple is elevated (P/E 24.6).

Valuation inputs: P/E 24.6, earnings yield +4.1%, momentum +0.5%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is acceptable (ROE +10.2%, ROIC +7.4%).

Profitability stack: net margin +6.3%, ROE +10.2%, ROIC +7.4%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +53.0%, momentum +0.5%, net margin +6.3%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

lh

Labcorp Holdings Inc. Market vs Earnings Trajectory

LH ยท NYSE

Loading price and EPS data...

Labcorp Holdings Inc.

Labcorp Holdings Inc. Fair Value Envelope

LH ยท NYSE

Our analysis suggests that LH has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $258.92, this represents a potential HIDDEN relative to our calculated worth for Labcorp Holdings Inc..

Intrinsic Value
Current Price: $258.92
3Y-25.0%
5Y-34.0%
10Y+48.0%
3Y+18.0%
5Y-
10Y+45.0%
3Y-31.0%
5Y-44.0%
10Y+20.0%
3Y-16.0%
5Y-23.0%
10Y+40.0%
3Y-18.0%
5Y-31.0%
10Y+34.0%
3Y-9.0%
5Y-8.0%
10Y+29.0%
Labcorp Holdings Inc.

Labcorp Holdings Inc. Profit Bridge

LH ยท NYSE
Revenue13.95B
Cost of Goods Sold (10.22B)
Gross Profit3.73B
Operating Expenses (2.22B)
Operating Income1.52B
Interest Expense (224.10M)
Other Income/Expense-408.70M
Pretax Income1.11B
Income Tax (229.80M)
Net Income876.50M
Net Income
876.50M

Profitability Analysis

Gross Margin

26.8%

Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.

Operating Margin

10.9%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

6.3%

Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.

Effective Tax Rate

20.7%

Moderate tax rate typical for most corporations. Represents standard tax burden on profits.

Profitability Insight

Room for improvement: Moderate profitability with opportunities to enhance margins through better cost management or pricing strategy.

26.75%
Gross Profit Margin
-4%
3Y-14.0%
5Y-24.0%
10Y-19.0%
10.87%
Operating Profit Margin
30%
3Y-10.0%
5Y-38.0%
10Y-20.0%
6.28%
Net Profit Margin
10%
3Y-42.0%
5Y-44.0%
10Y-17.0%
10.17%
Return on Equity
10%
3Y-20.0%
5Y-38.0%
10Y-24.0%
4.77%
Return on Assets
17%
3Y-25.0%
5Y-39.0%
10Y-7.0%
7.39%
Return on Invested Capital
42%
3Y+11.0%
5Y-24.0%
10Y+10.0%
LH

Labcorp Holdings Inc. Cash Conversion Engine

LH ยท NYSE
Net Income877.70M
Depreciation & Amortization681.10M
Stock-Based Compensation125.80M
Change in Working Capital-526.10M
Others384.40M
Capital Expenditures-434.50M
Free Cash Flow1.21B

Cash Flow Quality Analysis

FCF Conversion Rate

137.4%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

26.5%

Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.

FCF Growth Trend

+10.0%

Steady FCF growth indicates consistent cash generation improvement. On a positive trajectory.

Working Capital Impact

-$526.10M

Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.

Cash Flow Quality Insight

Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.

lh

Labcorp Holdings Inc. Funding & Solvency Profile

LH ยท NYSE
Cash & Cash Equivalents981.10M
Net Receivables2.29B
Inventory497.70M
Other Current Assets791.40M
Total Current Assets5 B
Property, Plant & Equipment3.07B
Goodwill & Intangible Assets10.59B
Long-Term Investments146.60M
Other Non-Current Assets724.90M
Total Non-Current Assets4 B
Total Assets
19.09B

Financial Health Analysis

Current Ratio

1.73x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

1.18x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

2 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

24% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

lh

Labcorp Holdings Inc. Street Expectations Map

LH ยท NYSE

Wall Street analysts project that LH stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 311.33, with estimates ranging from a low of 300.00 to a high of 334.00.

Lowest Target
300.00
15.87%
Consensus Target
311.33
20.24%
Highest Target
334.00
29.00%

The consensus 1-year price target stands at 311.33, with estimates ranging from a low of 300.00 to a high of 334.00.

Analyst Consensus Analysis

Upside Potential

+20.2%

Strong upside potential. Consensus indicates attractive return opportunity with favorable risk-reward profile.

Analyst Agreement

10.9% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Very High

Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.

Market Sentiment Insight

Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.

lh

Labcorp Holdings Inc. Insider Positioning

LH ยท NYSE

During the last 12 months, insiders have sold $14.60M worth of LH shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

8.4K

2.16M

Net Activity

-2.2M

-$2.16M

3-6 Months

Bought

0

0.00

Sold

17.0K

4.78M

Net Activity

-4.8M

-$4.78M

6-9 Months

Bought

0

0.00

Sold

12.8K

3.29M

Net Activity

-3.3M

-$3.29M

9-12 Months

Bought

0

0.00

Sold

16.1K

4.36M

Net Activity

-4.4M

-$4.36M

Top Buyers

No buying activity

Top Sellers

1
SAH

Schechter Adam H

Director, Officer: President & Ceo

31.3K sharesโ€ข5 transactions

$8.45M

2
PRP

Parham Richelle P

Director

7.0K sharesโ€ข1 transactions

$1.78M

3
AKB

Anderson Kerrii B

Director

4.5K sharesโ€ข3 transactions

$1.24M

4
VDVSD

Van Der Vaart Sandra D

Officer: Evp, Corporate Affairs

4.5K sharesโ€ข2 transactions

$1.22M

5
WPJ

Wilkinson Peter J

Officer: Svp, Chief Accounting Officer

2.4K sharesโ€ข3 transactions

$647K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $14.60M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$2.16M

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

0.28%
Dividend Yield
-3%
3Y-25.0%
5Y-
10Y-
ย 

lh Dividend History

LH
10Y CAGR 15%
Latest $0.72
Annual $3.6
Stable dividend payments
Last Period: +0%